News & stories

News | Nov 17, 2022

Lebanon: MSF vaccinates people against cholera as disease continues to spread

MSF increases prevention and treatment efforts in Lebanon amid unprecedented number of cholera outbreaks globally.

News | Nov 17, 2022

MSF publishes first clinical trial transparency policy

Open sharing of the costs of clinical trials and information could help expand access to lifesaving medicines, vaccines, and diagnostics.

Story | Nov 14, 2022

World Diabetes Day: How MSF is getting insulin to people who need it

Around the world, only half of the people living with type one diabetes have access to insulin.

Story | Nov 08, 2022

Video: Climate change worsens crises in Cameroon

News | Oct 27, 2022

With cases on the rise, MSF repeats call for more affordable DR-TB treatment

The price of a full DR-TB treatment course should be no more than $500 per person.

News | Oct 19, 2022

MSF responds to change in global cholera vaccine strategy amid unprecedented number of outbreaks

Story | Sep 23, 2022

Pakistan floods: MSF treats growing number of people with waterborne and mosquito-borne diseases

News | Sep 15, 2022

MSF: Cepheid’s production delays of critical tuberculosis test will cost lives

Story | Aug 25, 2022

Access (or not) to vaccines for mpox in Africa: a sense of déjà vu?

Mpox is endemic to Africa, and the widespread transmission to so many non-endemic countries in such a short period of time has been unprecedented.

News | Aug 19, 2022

Mpox should serve as a global health wake-up call about when we act and why

Mpox had just received little attention outside the endemic countries of West and Central Africa until recently, when wealthy nations were affected.